MERIDIAN DIAGNOSTICS INC
10-K, EX-27, 2000-12-22
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: MERIDIAN DIAGNOSTICS INC, 10-K, EX-23, 2000-12-22
Next: MERIDIAN DIAGNOSTICS INC, 10-K, EX-99, 2000-12-22



<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          SEP-30-2000
<PERIOD-START>                             OCT-01-1999
<PERIOD-END>                               SEP-30-2000
<CASH>                                           4,766
<SECURITIES>                                        13
<RECEIVABLES>                                   14,327
<ALLOWANCES>                                       438
<INVENTORY>                                     15,808
<CURRENT-ASSETS>                                40,166
<PP&E>                                          29,037
<DEPRECIATION>                                  11,150
<TOTAL-ASSETS>                                  84,769
<CURRENT-LIABILITIES>                           17,303
<BONDS>                                         20,000
                                0
                                          0
<COMMON>                                         2,530
<OTHER-SE>                                      34,081
<TOTAL-LIABILITY-AND-EQUITY>                    84,769
<SALES>                                         57,096
<TOTAL-REVENUES>                                57,096
<CGS>                                           21,650
<TOTAL-COSTS>                                   21,650
<OTHER-EXPENSES>                                26,092
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               2,124
<INCOME-PRETAX>                                  6,938
<INCOME-TAX>                                     (173)
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     7,111
<EPS-BASIC>                                       0.49
<EPS-DILUTED>                                     0.49


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission